Membrane Structure: Phospholipid Bilayer, Proteins, Glycocalyx

Membrane Structure: Phospholipid Bilayer, Proteins and Glycocalyx

The cell membrane is not a passive envelope. It is a dynamic, metabolically maintained, mechanically responsive, electrically active and chemically specialised organelle. For the Primary FRCA, membrane structure is foundational for understanding excitability, receptor pharmacology, anaesthetic mechanisms, local anaesthetic toxicity, capillary permeability, inflammation, fluid therapy and organ dysfunction in critical illness.

The canonical model is the fluid mosaic model, originally proposed by Singer and Nicolson in 1972, but modern membrane biology extends this with lipid rafts, caveolae, membrane-cytoskeleton coupling, glycocalyx biology and active membrane trafficking. The membrane is approximately 7.5 to 10 nm thick, has a specific capacitance of about 1 microfarad/cm2, and maintains steep ionic gradients using ATP-dependent transporters. These structural features are essential for the resting membrane potential, action potential propagation and receptor-mediated intracellular signalling.

Core architecture of the phospholipid bilayer

The plasma membrane consists of an amphipathic lipid bilayer. Each phospholipid has a hydrophilic polar head group and hydrophobic fatty acyl tails. In aqueous solution, this arrangement minimises free energy by orientating hydrophobic tails inward and polar head groups toward the extracellular fluid and cytosol.

Phospholipid composition is not random. Major phospholipids include phosphatidylcholine and sphingomyelin, predominantly in the outer leaflet, and phosphatidylethanolamine, phosphatidylserine and phosphatidylinositol, predominantly in the inner leaflet. This asymmetry is biologically essential.

Membrane asymmetry

Membrane asymmetry is maintained by ATP-dependent and ATP-independent lipid translocases:

• Flippases: move phosphatidylserine and phosphatidylethanolamine from outer to inner leaflet; ATP-dependent.
• Floppases: move lipids from inner to outer leaflet; often ATP-binding cassette transporter dependent.
• Scramblases: bidirectional, ATP-independent, calcium-activated enzymes that collapse asymmetry, particularly during apoptosis and platelet activation.

Externalisation of phosphatidylserine is a key signal in apoptosis and coagulation. In apoptosis, exposed phosphatidylserine promotes macrophage recognition and non-inflammatory clearance. In platelet activation, anionic phosphatidylserine provides a catalytic surface for tenase and prothrombinase complexes, accelerating thrombin generation. This is clinically relevant in sepsis, disseminated intravascular coagulation, transfusion medicine and extracorporeal circuits.

Fluidity, phase behaviour and cholesterol

Membrane fluidity depends on fatty acyl chain length, degree of unsaturation, temperature and cholesterol content. Shorter chains and cis-unsaturated bonds increase fluidity by reducing van der Waals packing. Saturated long-chain lipids increase order and raise the gel-to-liquid crystalline transition temperature.

Cholesterol has a bidirectional effect. At high temperatures it restrains phospholipid movement and reduces excessive fluidity; at low temperatures it prevents tight packing and preserves fluidity. It also reduces permeability to small water-soluble molecules and supports lipid raft formation. Cholesterol-rich microdomains organise receptors, signalling proteins and ion channels. This is important for beta-adrenoceptor signalling, nitric oxide signalling in caveolae, immune synapse formation and mechanotransduction.

The bilayer is laterally mobile. Lipids can diffuse laterally at approximately 1 micrometre per second, whereas transverse flip-flop is energetically unfavourable and slow without enzymes. Membrane proteins also diffuse laterally but are constrained by cytoskeletal anchoring, extracellular matrix interactions and compartmentalisation.

Membrane permeability and electrical properties

The lipid bilayer is highly permeable to hydrophobic molecules and relatively impermeable to charged or polar molecules. Permeability follows lipid solubility, molecular size, charge and availability of transport pathways.

The membrane behaves electrically as a capacitor: two conducting solutions separated by a non-conducting lipid dielectric. Specific membrane capacitance is approximately 1 microfarad/cm2. Myelination increases effective membrane resistance and reduces capacitance, accelerating saltatory conduction. This underpins the vulnerability of demyelinated nerves to conduction failure and the preferential block of small myelinated fibres by local anaesthetics.

Typical resting membrane potential is approximately -70 mV in neurones, -90 mV in skeletal muscle and ventricular myocytes, and more variable in smooth muscle. These potentials are generated by selective permeability, predominantly to potassium at rest, and maintained by the Na+/K+-ATPase, which exports 3 Na+ and imports 2 K+ per ATP, creating a net electrogenic outward positive current.

Membrane proteins: classification and structure-function relationships

Membrane proteins are the functional machinery of the cell membrane. They may be integral, peripheral, lipid-anchored or transiently associated. Their amphipathic structure enables stable association with the bilayer.

Ion channels

Ion channels are selective pores permitting rapid passive ion movement down electrochemical gradients. A single channel may conduct millions of ions per second. Gating may be voltage-dependent, ligand-gated, mechanically activated, temperature-sensitive or second-messenger regulated.

• Voltage-gated sodium channels: responsible for action potential upstroke. They contain alpha subunits with four homologous domains, each with six transmembrane segments. The S4 segment acts as the voltage sensor. Local anaesthetics bind preferentially to open and inactivated states from the intracellular side, producing use-dependent block.
• Voltage-gated calcium channels: L-type channels mediate excitation-contraction coupling in cardiac and smooth muscle; N- and P/Q-type channels mediate neurotransmitter release. Calcium channel blockers reduce afterload and myocardial oxygen demand.
• Potassium channels: determine resting membrane potential and repolarisation. ATP-sensitive K+ channels couple metabolism to excitability and are targets of sulfonylureas and volatile anaesthetic preconditioning pathways.
• Ligand-gated channels: include nicotinic acetylcholine receptors, GABA-A receptors, glycine receptors, NMDA receptors and 5-HT3 receptors. Many are central anaesthetic and analgesic targets.

Carrier proteins and pumps

Carriers undergo conformational change and are saturable. They can mediate facilitated diffusion, primary active transport or secondary active transport. Primary active transport directly uses ATP, whereas secondary active transport uses the electrochemical gradient established by primary transport.

Receptors and signal transduction

Membrane receptors translate extracellular signals into intracellular responses. Primary FRCA candidates should link receptor structure to drug action.

Important second messenger pathways include Gs activation of adenylyl cyclase increasing cAMP and protein kinase A activity; Gi inhibition of adenylyl cyclase; and Gq activation of phospholipase C generating IP3 and DAG. IP3 releases Ca2+ from the endoplasmic reticulum, while DAG activates protein kinase C. Beta1-adrenoceptor stimulation increases heart rate, conduction and contractility through cAMP-dependent phosphorylation of L-type Ca2+ channels, phospholamban and troponin I. Alpha1 stimulation causes vasoconstriction via Gq-mediated Ca2+ release and myosin light-chain kinase activation. Alpha2 agonists such as clonidine and dexmedetomidine reduce sympathetic outflow via Gi-mediated inhibition of presynaptic neurotransmitter release.

Membrane structure and anaesthetic pharmacology

Local anaesthetics and sodium channel membranes

Local anaesthetics are weak bases with an aromatic lipophilic group, intermediate ester or amide linkage, and tertiary amine. Their action requires membrane diffusion of the uncharged form and binding of the protonated form to the intracellular aspect of voltage-gated sodium channels. Blockade is state-dependent and frequency-dependent, explaining preferential block of rapidly firing pain fibres.

Acidosis increases the ionised fraction of local anaesthetic in plasma and reduces protein binding, increasing toxicity. Hyperkalaemia, hypoxia and pregnancy also increase susceptibility. In local anaesthetic systemic toxicity, current specialist guidance such as the Association of Anaesthetists lipid rescue approach recommends 20% lipid emulsion 1.5 mL/kg bolus over about 1 minute, followed by 15 mL/kg/hour infusion; the bolus may be repeated and infusion increased for persistent instability, with a commonly cited maximum total dose of approximately 12 mL/kg. Seizures should be treated with benzodiazepines; large doses of propofol should be avoided in cardiovascular collapse. Vasopressin, calcium channel blockers, beta-blockers and local anaesthetic antiarrhythmics are generally avoided.

General anaesthetics: membrane versus protein theories

Historic theories proposed that anaesthesia resulted from nonspecific lipid bilayer perturbation, supported by the Meyer-Overton correlation between lipid solubility and potency. Minimum alveolar concentration is inversely related to oil-gas partitioning for many volatile agents. However, exceptions such as non-immobilisers, stereoselectivity and specific receptor effects show that anaesthetics act substantially through membrane proteins.

Modern interpretation is not lipid versus protein, but lipid-protein coupling. The bilayer provides the mechanical and electrostatic environment in which ion channels and receptors function. Anaesthetics can partition into membranes, alter lateral pressure profiles, modify raft organisation and directly bind protein cavities. Volatile anaesthetics potentiate inhibitory GABA-A and glycine transmission, activate two-pore domain K+ channels such as TASK and TREK, inhibit excitatory nicotinic and NMDA receptor signalling, and reduce presynaptic neurotransmitter release.

The glycocalyx

The glycocalyx is a carbohydrate-rich layer coating the external surface of most cells. It is composed of glycoproteins, glycolipids and proteoglycans. In the vascular endothelium it forms a highly specialised, fragile, dynamic interface between blood and vessel wall.

Molecular composition

The endothelial glycocalyx contains:

• Proteoglycans: core proteins such as syndecans and glypicans bearing glycosaminoglycan side chains.
• Glycosaminoglycans: heparan sulphate, chondroitin sulphate, dermatan sulphate, keratan sulphate and hyaluronan. Heparan sulphate is often the dominant endothelial component.
• Glycoproteins: adhesion molecules, selectins, integrins and enzymes.
• Adsorbed plasma proteins: albumin, antithrombin, orosomucoid and other proteins contribute to charge and oncotic properties.

The endothelial glycocalyx thickness varies with vascular bed and measurement technique, but is commonly described as approximately 0.5 to 3 micrometres in vivo, much thicker than the lipid bilayer itself. It contributes to an intravascular exclusion zone and may contain a circulating volume equivalent of roughly 700 to 1700 mL in adults, although estimates vary. It is negatively charged, largely due to sulphated glycosaminoglycans and sialic acid residues.

Functions of the glycocalyx

The revised Starling principle is a high-yield viva topic. Classical Starling forces described outward filtration at the arteriolar end and reabsorption at the venular end. Modern understanding emphasises that the endothelial glycocalyx creates a low-protein subglycocalyx space. The effective oncotic gradient is between plasma and this subglycocalyx, not plasma and interstitium. In most continuous capillaries, steady-state venous reabsorption is limited; excess filtered fluid returns predominantly via lymphatics. When the glycocalyx is damaged, protein-rich fluid crosses more readily, increasing interstitial oedema and reducing the sustained intravascular volume effect of colloids.

Glycocalyx injury in anaesthesia and critical illness

Glycocalyx shedding occurs in sepsis, trauma, burns, hypervolaemia, ischaemia-reperfusion, diabetes, inflammatory states and major surgery. Enzymatic mediators include heparanase, hyaluronidase, matrix metalloproteinases and reactive oxygen species. Biomarkers include syndecan-1, heparan sulphate and hyaluronan, although they are mainly research tools rather than routine clinical tests.

Clinical consequences include capillary leak, tissue oedema, microvascular thrombosis, impaired oxygen diffusion, leukocyte adhesion and organ dysfunction. In acute respiratory distress syndrome, glycocalyx degradation contributes to alveolar-capillary leak. In acute kidney injury, endothelial and glomerular glycocalyx injury contributes to proteinuria and microvascular dysfunction. KDIGO defines acute kidney injury as any of: increase in serum creatinine by 26.5 micromol/L or more within 48 hours, increase to 1.5 times baseline within 7 days, or urine output below 0.5 mL/kg/hour for 6 hours; membrane and endothelial injury contribute mechanistically to several AKI phenotypes.

Fluid therapy implications

Anaesthetic relevance is substantial. Excess crystalloid can worsen endothelial glycocalyx injury through atrial natriuretic peptide release during acute hypervolaemia, dilution of plasma proteins and increased hydrostatic filtration. Balanced crystalloids are generally preferred over 0.9% saline for many perioperative and critical care contexts because high-chloride saline can cause hyperchloraemic metabolic acidosis and renal vasoconstriction. The SMART and SALT-ED pragmatic trials, both published in 2018, found modest but statistically significant reductions in major adverse kidney events with balanced crystalloids compared with saline in critically ill and non-critically ill adults respectively. Effect sizes were small, but clinically relevant at population level.

Surviving Sepsis Campaign 2021 guidelines suggest at least 30 mL/kg intravenous crystalloid within the first 3 hours for sepsis-induced hypoperfusion or septic shock, while emphasising reassessment and dynamic measures of fluid responsiveness. In a glycocalyx-centred interpretation, indiscriminate fluid loading after initial resuscitation may worsen oedema and organ dysfunction. Dynamic indices such as passive leg raise response, stroke volume variation and pulse pressure variation are preferable to static filling pressures when applicable. Pulse pressure variation is most reliable in fully mechanically ventilated patients with tidal volume around 8 mL/kg, sinus rhythm, closed chest and no major right ventricular dysfunction.

Albumin may support glycocalyx integrity experimentally by binding to the glycocalyx and maintaining oncotic gradients. Clinically, albumin has not shown universal mortality benefit. The SAFE trial in 2004 found similar 28-day mortality between 4% albumin and saline in ICU resuscitation, with subgroup signals of possible harm in traumatic brain injury and possible benefit in sepsis. The ALBIOS trial in 2014 did not demonstrate overall mortality reduction with albumin replacement in severe sepsis, although some subgroup analyses suggested benefit in septic shock. Thus, albumin is not a routine glycocalyx rescue drug, but may be considered in selected patients requiring substantial crystalloid volumes, depending on local guidance.

Membrane specialisations

Lipid rafts and caveolae

Lipid rafts are cholesterol- and sphingolipid-rich microdomains that concentrate signalling molecules. Caveolae are flask-shaped invaginations enriched in caveolin proteins, particularly caveolin-1 in endothelium and caveolin-3 in muscle. They are involved in endocytosis, mechanosensing and nitric oxide signalling. Endothelial nitric oxide synthase is inhibited by caveolin-1 binding and activated following calcium-calmodulin displacement, phosphorylation and shear stress signalling. Disruption of caveolae modifies vascular tone and inflammatory responses.

Cell junctions

Membrane proteins form intercellular junctions. Tight junctions regulate paracellular permeability and are critical in the blood-brain barrier. Adherens junctions use cadherins linked to actin through catenins and maintain endothelial integrity. Desmosomes provide mechanical strength, especially in epithelium and myocardium. Gap junctions composed of connexins allow electrical and metabolic coupling; connexin-43 is important in ventricular myocardium. Volatile agents and acidosis can alter gap junction coupling, relevant to arrhythmogenesis and myocardial conduction.

Pathophysiological and clinical correlations

Investigating membrane-related dysfunction

Although membrane structure itself is not directly investigated in routine anaesthetic practice, membrane dysfunction is inferred from physiology and targeted tests. Ion channel disease may require ECG, exercise testing, genetic testing and electrolyte assessment. Neuromuscular junction membrane disorders require nerve stimulation studies, antibody assays and pulmonary function assessment. Glycocalyx injury is currently inferred clinically through capillary leak, oedema, hypoalbuminaemia, shock and organ dysfunction; syndecan-1 and heparan sulphate assays remain research-oriented.

In local anaesthetic toxicity, diagnosis is clinical: circumoral numbness, tinnitus, metallic taste, agitation, seizures, reduced consciousness, conduction delay, hypotension, ventricular arrhythmias and cardiac arrest. Plasma concentrations are rarely useful acutely. Management is immediate cessation of injection, airway oxygenation and ventilation, seizure control, lipid emulsion and modified advanced life support. In suspected malignant hyperthermia, investigate arterial or venous blood gases, potassium, creatine kinase, myoglobin, coagulation, renal function and temperature; definitive susceptibility testing may involve genetic testing and in vitro contracture testing where available.

High-yield viva discussion points

• Why is the membrane a capacitor? Conductive intra- and extracellular fluids are separated by an insulating lipid bilayer. Charge separation across a very thin dielectric stores electrical energy, so small ionic movements can markedly alter voltage without significantly changing bulk ionic concentrations.
• Why are charged ions unable to cross lipid membranes freely? Hydration shells and charge make entry into the hydrophobic membrane core energetically unfavourable. Ion channels provide selectivity filters and aqueous pores that lower the energy barrier.
• Why does acidosis increase local anaesthetic toxicity but reduce block onset in infected tissue? Acidosis increases protonated drug, reducing membrane-permeant unionised fraction and slowing nerve penetration. Systemically, acidosis increases free active drug, reduces protein binding and worsens cardiac sodium channel blockade.
• Why is the glycocalyx important in fluid therapy? It determines effective oncotic gradients and endothelial permeability. Damage converts the vasculature into a leaky barrier, reducing intravascular persistence of fluids and increasing interstitial oedema.
• What has replaced a purely lipid theory of anaesthesia? A protein-target model integrated with membrane biophysics: anaesthetics bind specific ion channels and receptors, while the lipid bilayer modulates protein conformation, localisation and signalling.

Summary for examination practice

The plasma membrane is a phospholipid bilayer containing cholesterol, proteins and carbohydrate-rich surface structures. Its lipid core creates selective permeability; its protein components enable transport, excitability, adhesion and signal transduction; and its glycocalyx regulates vascular barrier function, inflammation and coagulation. For the anaesthetist, membrane physiology explains action potentials, local anaesthetic blockade, volatile anaesthetic pharmacology, receptor mechanisms, capillary leak, neuromuscular disease, arrhythmias and perioperative organ dysfunction. A strong viva answer should move beyond the phrase fluid mosaic model and integrate molecular structure with clinical physiology and pharmacology.